Why Is INSPIRE MED SYS INC (INSP) Stock Up Today?

Inspire Medical Systems Inc stock rose 5.65 percent to $71.97 on Friday, driven by a price target increase from Stifel and broader market speculation around the company's future performance. The stock opened at $68.05 and reached an intraday high of $72.27, closing near the session peak. The move reflects renewed investor interest in the healthcare sector and positive analyst sentiment.

What Happened

Stifel raised its price target for Inspire Medical Systems from $75 to $80, signaling confidence in the company's growth trajectory. This upgrade came amid a broader trend of analyst activity, including upgrades from Oppenheimer and Mizuho, and a price target increase from Truist Securities. These actions suggest a consensus among analysts that the company is undervalued or poised for strong performance. Meanwhile, Inspire Brands, a separate entity, announced that Scott Murphy, Dunkin’s brand president, has been named interim CEO ahead of a potential IPO. While Inspire Brands is a distinct company, the news generated cross-sector attention and may have contributed to the broader Inspire-related stock movement.

What The Data Shows

Inspire Medical Systems has a market capitalization of $1.9 billion and a price-to-earnings ratio of 14.8. The company reported a 4.3 percent year-to-date revenue increase and maintains a net margin of 15.0 percent. The stock traded at 0.70 beta, indicating lower volatility than the market. The stock's 52-week range is between $38.91 and $147.03, and it printed a fresh 52-week high on September 11. Volume remained at 0.0 million shares, below the 3-month average. Recent insider transactions show one sale totaling $57,000, while congressional trades include recent sales and purchases by Donald J. Trump.

What To Watch

Investors should monitor the company's upcoming earnings report and any further analyst activity. Coverage breadth is increasing, with seven stories from six sources in the last 36 hours.